New hope for hepatitis b: experimental drug Tune-401 enters human testing
Disease control
Recruiting now
This early-stage study tests the safety of a new drug, Tune-401, in 36 adults with chronic hepatitis B. Participants must already be on standard antiviral therapy. The main goal is to see if the drug is safe and how the body processes it. This is not a cure, but a step toward bet…
Phase: PHASE1 • Sponsor: Tune Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 05:47 UTC